Thomas Pietschmann

12.5k citations

78 papers · 9.1k indexed · 2 hit papers · h-index 45

Impact in

Hepatology top 0.05%
- Hepatitis C virus research
Virology top 0.5%
- HIV Research and Treatment

Papers in

Hepatology 67
- Hepatitis C virus research 67
Virology 16
- HIV Research and Treatment 16

Co-authors: Ralf Bartenschlager Eike Steinmann Stephanie Kallis Volker Lohmann Takaji Wakita George Koutsoudakis Hans‐Georg Kräusslich T. Jake Liang
Journals: Journal of Virology (23 papers)Hepatology (6 papers)PLoS Pathogens (6 papers)Journal of Biological Chemistry (5 papers)The Journal of Infectious Diseases (5 papers)
Partner nations: Germany United States France

In The Last Decade

Thomas Pietschmann

76 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras 2006 · 588 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Proceedings of the National Academy of Sciences
2005 Nature Medicine

Peers

Countries citing papers authored by Thomas Pietschmann

Since Specialization

Citations

This map shows the geographic impact of Thomas Pietschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pietschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pietschmann more than expected).

Fields of papers citing papers by Thomas Pietschmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pietschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pietschmann. The network helps show where Thomas Pietschmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Pietschmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Pietschmann Line = papers co-authored together Thomas Pietschmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model Clinical Infectious Diseases ·T. Jake Liang, John Law, Thomas Pietschmann, Stuart C. Ray, Jens Bukh, Rowena A. Bull, Raymond T. Chung, D. Lorne Tyrrell, Michael Houghton, Charles M. Rice	2023	4
2	A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes Gastroenterology ·Sibylle Haid, Alcione Cavalheiro, Juliane Gentzsch, Lindsey Millward, 直親浅井, Dorothea Bankwitz, Patrick Chhatwal, Fabio Taschetti, Thierry Hennebelle, François Bailleul, Oliver T. Keppler, Marion Poenisch, Ralf Bartenschlager, Céline Hernandez, Matthieu Lemasson, Arielle R. Rosenberg, Flossie Wong‐Staal, Elisabeth Davioud–Charvet, Thomas Pietschmann	2012	94
3	Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication PLoS ONE ·Patrick Chhatwal, Dorothea Bankwitz, Juliane Gentzsch, Anne Frentzen, Philipp Schult, Volker Lohmann, Thomas Pietschmann	2012	21
4	Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro Antiviral Research ·良浩土井, Matthew P. Wilson, David Back, Heiner Wedemeyer, Michael P. Manns, Eike Steinmann, Thomas Pietschmann, Thomas von Hahn, Sandra Ciesek	2012	2
5	Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces The Journal of Infectious Diseases ·Juliane Doerrbecker, Martina Friesland, Sandra Ciesek, Thomas Erichsen, Pedro Mateu‐Gelabert, Jörg Steinmann, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann	2011	86
6	NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus Journal of Biological Chemistry ·Roland Montserret, Nathalie Saint, Christophe Vanbelle, Andrés G. Salvay, Jean‐Pierre Simorre, Christine Ebel, Nicolas Sapay, 景繁金澤, Anja Böckmann, Eike Steinmann, Thomas Pietschmann, Jean Dubuisson, Christophe Chipot, François Pénin	2010	112
7	The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry Hepatology ·Sandra Ciesek, Thomas von Hahn, Che C. Colpitts, Luis M. Schang, Martina Friesland, Jörg Steinmann, Michael P. Manns, Michael Ott, Heiner Wedemeyer, Philip Meuleman, Thomas Pietschmann, Eike Steinmann	2010	247
8	How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides The Journal of Infectious Diseases ·Sandra Ciesek, Martina Friesland, Jörg Steinmann, Britta Becker, Heiner Wedemeyer, Michael P. Manns, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann	2010	62
9	Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus Gastroenterology ·Sandra Ciesek, Eike Steinmann, Haríz Islas Flores, Michael Ott, Fabian Helfritz, Ilka Wappler, Michael P. Manns, Heiner Wedemeyer, Thomas Pietschmann	2010	60
10	Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity Antiviral Research ·Juliane Gentzsch, Elin Åkelius, Lars Kaderali, Herbert Irschik, Rolf Jansen, Florenz Sasse, Ronald Frank, Thomas Pietschmann	2010	36
11	Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations PLoS Pathogens ·Thomas Pietschmann, Margarita Zayas, Philip Meuleman, Gang Long, Nicole Appel, George Koutsoudakis, Stephanie Kallis, Geert Leroux‐Roels, Volker Lohmann, Ralf Bartenschlager	2009	107
12	Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles Journal of Biological Chemistry ·Sibylle Haid, Thomas Pietschmann, Eve‐Isabelle Pécheur	2009	72
13	Full-Length Infectious HCV Chimeras Methods in molecular biology ·Thomas Pietschmann	2009	7
14	Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 Hepatology ·Mirjam B. Zeisel, George Koutsoudakis, H. Lode, Anita Haberstroh, Hubert E. Blum, François–Loïc Cosset, Takaji Wakita, Daniel Jaeck, Michel Doffoël, Cathy Royer, Eric Soulier, Évelyne Schvoerer, Catherine Schuster, Françoise Stoll‐Keller, Ralf Bartenschlager, Thomas Pietschmann, Heidi Barth, Thomas F. Baumert	2007	185
15	Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions PLoS Pathogens ·Eike Steinmann, François Pénin, Stephanie Kallis, Arvind H. Patel, Ralf Bartenschlager, Thomas Pietschmann	2007	276
16	Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras Proceedings of the National Academy of Sciences ·Thomas Pietschmann, Artur Kaul, George Koutsoudakis, Anna Shavinskaya, Stephanie Kallis, Eike Steinmann, Karim Abid, Francesco Negro, Marlène Dreux, François–Loïc Cosset, Ralf Bartenschlager Hit paper breakdown →	2006	588
17	High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI Journal of Biological Chemistry ·Marlène Dreux, Thomas Pietschmann, Christelle Granier, Cécile Voisset, Sylvie Ricard‐Blum, Philippe Mangeot, Zhen–Yong Keck, Steven K. H. Foung, Ngoc Vu‐Dac, Jean Dubuisson, Ralf Bartenschlager, Dimitri Lavillette, François–Loïc Cosset	2006	177
18	Novel Insights into Hepatitis C Virus Replication and Persistence Advances in virus research ·Ralf Bartenschlager, Michael Frese, Thomas Pietschmann	2004	214
19	Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection Virology ·Frank C. Hladky, Thomas Pietschmann, Axel Rethwilm, Dirk Lindemann	2003	17
20	Specific Binding of Recombinant Foamy Virus Envelope Protein to Host Cells Correlates with Susceptibility to Infection Virology ·Ottmar Herchenröder, Dieter Moosmayer, Michael Bock, Thomas Pietschmann, Axel Rethwilm, Paul D. Bieniasz, Myra O. McClure, Roland Weís, Josef Schneider	1999	15

About Thomas Pietschmann

Thomas Pietschmann is a scholar working on Hepatology, Virology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Transplantation, having authored 78 papers that have together received 9.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (67 papers), Hepatitis B Virus Studies (53 papers), Liver Disease Diagnosis and Treatment (22 papers), HIV Research and Treatment (16 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Viral Infections and Immunology Research (7 papers), Virus-based gene therapy research (5 papers) and Virology and Viral Diseases (5 papers). The work is most often cited by research in Hepatology (7.0k citations), Virology (1.0k citations), Epidemiology (6.0k citations), Animal Science and Zoology (592 citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Thomas Pietschmann has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Ralf Bartenschlager, Eike Steinmann, Stephanie Kallis, Volker Lohmann, Takaji Wakita, George Koutsoudakis, Hans‐Georg Kräusslich, T. Jake Liang, Takanobu Kato and Masashi Mizokami. Their work appears in journals such as Journal of Virology, Hepatology, PLoS Pathogens, Journal of Biological Chemistry and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact